Zimmer Biomet Holdings, Inc.
ZBH
Rank in Stocks
#1248
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing... Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Share Price
$95.94
Last synced: 2026-10-20
Market Cap
$18.30B
Change (1 day)
0.92%
Change (1 year)
-6.57%
Country
US
Trade Zimmer Biomet Holdings, Inc. (ZBH)
Category
Healthcare
Revenue for Zimmer Biomet Holdings, Inc. (ZBH)
Revenue in Jun 2026 TTM: $8.51B
According to Zimmer Biomet Holdings, Inc. latest financial reports the company's current revenue (TTM) is $8.51B. In 2024 the company made a revenue of $7.68B an increase over the revenue in the year 2023 that was $7.39B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Zimmer Biomet Holdings, Inc. from 2000 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $8.51B | 3.37% |
| 2025 | $8.23B | 7.20% |
| 2024 | $7.68B | 3.85% |
| 2023 | $7.39B | 6.55% |
| 2022 | $6.94B | 1.65% |
| 2021 | $6.83B | 11.42% |
| 2020 | $6.13B | -23.24% |
| 2019 | $7.98B | 0.62% |
| 2018 | $7.93B | 1.66% |
| 2017 | $7.80B | 1.76% |
| 2016 | $7.67B | 27.85% |
| 2015 | $6.00B | 28.34% |
| 2014 | $4.67B | 1.08% |
| 2013 | $4.62B | 3.39% |
| 2012 | $4.47B | 0.45% |
| 2011 | $4.45B | 5.49% |
| 2010 | $4.22B | 3.05% |
| 2009 | $4.10B | -0.62% |
| 2008 | $4.12B | 5.74% |
| 2007 | $3.90B | 11.50% |
| 2006 | $3.50B | 6.37% |
| 2005 | $3.29B | 10.24% |
| 2004 | $2.98B | 56.81% |
| 2003 | $1.90B | 38.52% |
| 2002 | $1.37B | 16.44% |
| 2001 | $1.18B | 13.26% |
| 2000 | $1.04B | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $46.59B | 447.49% |
US
|
|
| $35.48B | 317.02% |
IE
|
|
| $25.84B | 203.65% |
US
|
|
| $21.00B | 146.75% |
US
|
|
| - | - |
DE
|
